---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-028136"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2022-10-11T23:59:59+00:00"
generated_at: "2026-06-23T04:20:24.176152+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics prices $5.1M public offering of 3.78M units at $1.35/unit

## Summary
- Gross proceeds $5.1M from sale of 3,777,778 units; net proceeds estimated ~$4.454M.
- Each unit: 1 common share plus Series A ($1.62), B ($1.35), C ($2.16) warrants, 5-year term.
- Series C warrant cashless exercise trigger: 15 days after issuance or $10M common stock volume traded.
- Underwriters granted 45-day over-allotment option for up to 566,666 additional shares/warrants.
- Closing expected October 12, 2022; WallachBeth Capital acting as sole book-running manager.

## SEC filing metadata
- accession: 0001493152-22-028136
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2022-10-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315222028136/0001493152-22-028136-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315222028136/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-028136
- JSON: https://secwatch.observer/filing/0001493152-22-028136.json
- Plain text: https://secwatch.observer/filing/0001493152-22-028136.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.